Nisa Investment Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-27,900
| Closed | -$1.46M | – | 2411 |
|
|
2020
Q3 | $1.46M | Buy |
27,900
+2,470
| +10% | +$102K | 0.01% | 686 |
|
|
2020
Q2 | $846K | Buy |
25,430
+19,390
| +321% | +$617K | 0.01% | 842 |
|
|
2020
Q1 | $164K | Buy |
6,040
+1,270
| +27% | +$35.4K | ﹤0.01% | 1246 |
|
|
2019
Q4 | $94K | Buy |
4,770
+4,100
| +612% | +$65.6K | ﹤0.01% | 1451 |
|
|
2019
Q3 | $9K | Buy |
670
+280
| +72% | +$3.38K | ﹤0.01% | 1824 |
|
|
2019
Q2 | $5K | Hold |
390
| – | – | ﹤0.01% | 1913 |
|
|
2019
Q1 | $6K | Hold |
390
| – | – | ﹤0.01% | 1888 |
|
|
2018
Q4 | $4K | Hold |
390
| – | – | ﹤0.01% | 1866 |
|
|
2018
Q3 | $10K | Sell |
390
-330
| -46% | -$8.92K | ﹤0.01% | 1745 |
|
|
2018
Q2 | $15K | Buy |
720
+240
| +50% | +$5.15K | ﹤0.01% | 1609 |
|
|
2018
Q1 | $9K | Sell |
480
-300
| -38% | -$5K | ﹤0.01% | 1696 |
|
|
2017
Q4 | $11K | Hold |
780
| – | – | ﹤0.01% | 1728 |
|
|
2017
Q3 | $14K | Hold |
780
| – | – | ﹤0.01% | 1650 |
|
|
2017
Q2 | $13K | Buy |
780
+250
| +47% | +$3.81K | ﹤0.01% | 1645 |
|
|
2017
Q1 | $7K | Sell |
530
-470
| -47% | -$7.36K | ﹤0.01% | 1775 |
|
|
2016
Q4 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 1725 |
|
|
2016
Q3 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 1776 |
|
|
2016
Q2 | $11K | Buy |
+1,000
| New | +$10.3K | ﹤0.01% | 1785 |
|
Nisa Investment Advisors's MNTA Position: Q4 2020 in Review
Nisa Investment Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 27,900 shares — an estimated $1.46M sold.
Nisa Investment Advisors first reported a position in MNTA in Q2 2016 and held it in 18 quarters. The position peaked at $1.46M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Nisa Investment Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Nisa Investment Advisors sold 27,900 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.46M.
- Nisa Investment Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 18 quarters.
- Nisa Investment Advisors's Momenta Pharmaceuticals, Inc. position peaked at $1.46M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Nisa Investment Advisors's 13F filing for Q4 2020, filed 25 Jan 2021.